跳至主要内容
临床试验/NCT01708512
NCT01708512已完成不适用

Feasibility Study: Evaluation of the Ulthera® System for Lifting and Tightening of Facial and Neck Skin Laxity Using a Customized, High-Density and Vectoring Treatment Approach

Ulthera, Inc2 个研究点 分布在 1 个国家目标入组 21 人开始时间: 2012年4月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Ulthera, Inc
入组人数
21
试验地点
2
主要终点
Improvement in overall lifting and tightening of the skin

研究概览

简要总结

All enrolled subject will receive one Ultherapy™ treatment. Study images will be obtained pre-treatment, immediate post-treatment, and at each study follow-up visit. Enrolled subjects will return for follow-up visits at 90 days, 180 days and 365 days post-treatment.

详细描述

This is a prospective, single-center clinical trial to evaluate the efficacy of the Ulthera® System to provide a customized, high-density, vectored Ultherapy™ treatment to lift and tighten the skin of the face and neck. Skin laxity changes from baseline will be assessed at study follow-up visits. Global Aesthetic Improvement Scale scores and patient satisfaction questionnaires will also be obtained.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
25 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female, aged 25 to 60 years.
  • Subject in good health.
  • Skin laxity in the area(s) to be treated.
  • Understands and accepts the obligation not to undergo any other procedures in the area(s) to be treated through the follow-up period.
  • Willingness and ability to comply with protocol requirements, including returning for follow-up visits and abstaining from exclusionary procedures for the duration of the study.

排除标准

  • Presence of an active systemic or local skin disease that may affect wound healing.
  • Severe solar elastosis.
  • Excessive subcutaneous fat in the area(s) to be treated.
  • Excessive skin laxity on the area(s) to be treated.
  • Significant scarring in area(s) to be treated.
  • Open wounds or lesions in the area(s) to be treated.
  • Severe or cystic acne on the area(s) to be treated.
  • Presence of a metal stent or implant in the area(s) to be treated.
  • Inability to understand the protocol or to give informed consent.
  • BMI equal to and greater than 30.

研究组 & 干预措施

Ultherapy™ study treatment

Experimental

Each subject will receive a customized, high-density, vectored Ulthera System Treatment.

干预措施: Ulthera System Treatment (Device)

结局指标

主要结局

Improvement in overall lifting and tightening of the skin

时间窗: 90 days post-treatment

As determined by a masked, qualitative assessment of photographs at 90 days post treatment compared to baseline. The clinical response of Ulthera treatment will be assessed by comparing photographic images taken before and after the procedure.

次要结局

  • Overall aesthetic improvement(365 days post-treatment)

研究者

发起方
Ulthera, Inc
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Feasibility Study: Higher Density Ulthera® System... | 临床试验